Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Akhilesh Sivakumar"'
Autor:
Akram M. Shayeb, Hannah Dzimitrowicz McManus, Danielle Urman, Chinmay Jani, Tian Zhang, Nazli Dizman, Luis Meza, Akhilesh Sivakumar, Chun L. Gan, Pedro Barata, Mehmet A. Bilen, Xin Gao, Daniel Heng, Sumanta Pal, Ravi Narra, Deepak Kilari, Marina D. Kaymakcalan, Bradley McGregor, Toni K. Choueiri, Rana R. McKay
Publikováno v:
Clinical Genitourinary Cancer. 21:55-62
In patients with renal cell carcinoma (RCC) on cabozantinib, venous thromboembolism (VTE) management remains challenging due to limited safety data regarding direct oral anticoagulants (DOACs) use in conjunction with cabozantinib. We investigated the
Autor:
Akhilesh Sivakumar, Evan B. Bryson, Kevin H. Hall, Kathryn T. Maples, Subir Goyal, Nisha S. Joseph, Craig C. Hofmeister, Jonathan L. Kaufman, Sagar Lonial, Ajay K. Nooka, Robert Donald Harvey
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 42:233-240
Melphalan is an alkylating agent used in both autologous (ASCT) and allogeneic stem cell transplantation. It is a substrate of L-type amino acid transporter-1 (LAT-1) and LAT-2, which are involved in its tissue penetration and elimination. Gabapentin
Autor:
Chao Zhang, Tyler Beardslee, Akhilesh Sivakumar, Subir Goyal, Sarah Caulfield, Mehmet Asim Bilen
Publikováno v:
Oncologist
Background Patients with cancer are at higher risk for venous thromboembolism (VTE) and bleeding, in turn complicating anticoagulant therapy. An added complexity is the toxicity profile of agents used to treat certain cancers, namely the vascular end
Autor:
Bradley Alexander McGregor, Hannah Dzimitrowicz, Rana R. McKay, Marina D. Kaymakcalan, Akram Mesleh Shayeb, Nazli Dizman, Tian Zhang, Toni K. Choueiri, Danielle Urman, Daniel Y.C. Heng, Sumanta K. Pal, Akhilesh Sivakumar, Xin Gao, Pedro C. Barata, Luis Meza, Mehmet Asim Bilen, Chun Loo Gan
Publikováno v:
Journal of Clinical Oncology. 39:291-291
291 Background: Venous thromboembolism (VTE) is the second leading cause of death in patients with cancer. Despite cabo improving RCC outcomes, VTE management in these patients remains a challenge, partly due to poor understanding of cabo safety prof
Autor:
Akhilesh Sivakumar, Kapil Raghuraman, Nicholas Streck, Courtney Mountain, Anirudh Damughatla, Wendy Metz, Kristyn Sturms, Lucas Rose, Kenneth C. Williams, Michael Blue, Paige M. Bracci, Larry S. Schlesinger, Frederick Cope, Wael N. Jarjour, Kevin Ricks, Michael S. McGrath, Allison Beverly, Kaeli Parcel, David Ralph, Bonnie Chandler Abbruzzese, James Sanders, Joshua Walker, Nicholas A. Young, Amifred Williams, Toby Maurer, Thomas J. Rosol, Abul K. Azad, Bryan Wang, Wiam Bshara, Murugesan V. S. Rajaram, Erin Neylon, Jane Zhang, Mark Larsen, Spencer C. Behr, Brooke Blay, Christopher Wasco
Publikováno v:
Nuclear Medicine and Biology. 43:837